Crizotinib 250mg Capsules
Crizotinib 250mg capsules are used to treat certain types of lung cancer prevalent in humans. The medication falls under the category of anti-cancer medicines. It comes under the international brand name of Xalkori and in Indian or generic brand name of Crizalk.
The Crizalk capsules work by slowing down or stopping the rapid growth of lung cancer cells in the user’s body. The medication belongs to the category of kinase inhibitors. The capsules of Xalkori inhibit the further growth of lung cancer cells by binding with it.
Crizalk capsules can interact with some sort of drugs that may slow the heart rate. The interactions can be with clonidine, digoxin, beta-blockers, metoprolol, diliazem, etc. some other types of medications can also block the working of these tablets like azole antifungals, macrolide antibiotics, rifabutin, etc.
1. What is Crizalk 250 mg Capsule?
Crizalk 250 mg Capsule contains crizotinib, an anticancer medicine belonging to the kinase inhibitor group. Lotus International lists Crizalk as the Indian or generic brand corresponding to the international brand Xalkori.
2. What is Crizalk (Crizotinib) used for?
Crizalk is used to treat certain types of lung cancer. Crizotinib works by targeting specific proteins involved in the growth of cancer cells and may help slow or stop their growth.
3. How should Crizalk 250 mg Capsules be taken?
Crizalk should be taken orally exactly as prescribed by the treating doctor. The capsule should be swallowed whole with water and should not be chewed, crushed, or broken.
4. Can Crizalk be taken with food?
According to the Lotus International product information, Crizalk may be taken with or without food. Patients should follow the dosing schedule provided by their healthcare professional and avoid grapefruit or grapefruit-containing products unless advised otherwise.
5. What are the possible side effects of Crizalk?
Possible side effects may include diarrhea, nausea, vomiting, dizziness, headache, tiredness, loss of appetite, constipation, joint pain, mouth sores, changes in taste, fever, and chills. Patients should report persistent or severe symptoms to their healthcare professional.